ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

CGEM Cullinan Therapeutics Inc

22.79
0.11 (0.49%)
After Hours
Last Updated: 16:02:30
Delayed by 15 minutes

Period:

Draw Mode:

Volume 303,966
Bid Price 22.35
Ask Price 23.23
News -
Day High 23.12

Low
7.64

52 Week Range

High
30.1886

Day Low 22.35
Company Name Stock Ticker Symbol Market Type
Cullinan Therapeutics Inc CGEM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.11 0.49% 22.79 16:02:30
Open Price Low Price High Price Close Price Prev Close
22.78 22.35 23.12 22.79 22.68
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
5,951 303,966 $ 22.77 $ 6,921,302 - 7.64 - 30.1886
Last Trade Time Type Quantity Stock Price Currency
16:32:40 5 $ 22.35 USD

Cullinan Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
981.9M 43.07M - 0 -153.16M -3.56 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cullinan Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CGEM Message Board. Create One! See More Posts on CGEM Message Board See More Message Board Posts

Historical CGEM Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week23.1524.986922.2723.18541,853-0.36-1.56%
1 Month28.2230.188622.2725.83755,350-5.43-19.24%
3 Months17.4230.188614.9821.86796,1025.3730.83%
6 Months8.6730.18867.6419.25568,81114.12162.86%
1 Year10.1230.18867.6416.83392,74612.67125.20%
3 Years29.9137.607.3015.85305,067-7.12-23.80%
5 Years42.0059.857.3018.18300,976-19.21-45.74%

Cullinan Therapeutics Description

Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.